Clinical Trials in Miami

Showing 6701-6720 of 11,431 trials

Effect of Hepatic Impairment on LDE225..

NCT01764776

This study is to evaluate the pharmacokinetics and safety of 800 mg of LDE225 in subjects with impaired hepatic function and healthy subjects with normal hepatic function.

Normal Hepatic FunctionImpaired Hepatic Function

Novartis Pharmaceuticals33 participantsStarted Mar 2013

Miami, Florida, United States • Brussels, Belgium • Sofia, Bulgaria +2 more locations

COMPLETEDNA< 1 mile

Motivational Interviewing to Increase PrEP Uptake (MI-PrEP)

NCT03592719

The purpose of this study is to test a counseling program for Black women at high risk for HIV

Risk Factor

University of Miami50 participantsStarted Oct 2018

Miami, Florida, United States

COMPLETEDPhase 2< 1 mile

A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia

NCT01594983

This study is to determine a dose response signal for LCQ908 monotherapy and to assess the efficacy and safety of adding LCQ908 to Lovaza or fenofibrate.

Non Familial Chylocmicronemia Syndrome (Non-FCS)

Novartis Pharmaceuticals58 participantsStarted Jun 2012

Muscle Shoals, Alabama, United States • Glendale, Arizona, United States • Encinitas, California, United States +29 more locations

Effect of Hepatic Impairment on LDE225..

Motivational Interviewing to Increase PrEP Uptake (MI-PrEP)

A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia

Find Trials by Condition in Miami

Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function

Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763

A Multi-center Study to Assess the Effects of BYM338 on Skeletal Muscle in Sarcopenic Adults

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients

Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients

Helicobacter Pylori Genome Project (HpGP)

Safety Study of LBH589 When Given in Combination With Lenalidomide and Dexamethasone in Adult Patients With Multiple Myeloma.

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol

Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)

A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.